tiprankstipranks
Acasti Pharma, Inc. (ACST)
NASDAQ:ACST

Acasti Pharma (ACST) Ownership - Who Owns Acasti Pharma?

1,122 Followers

Recent Insider Trading Activity

Date
Name
Activity
Value
Sep 27, 2023
Vimal Kavuru
Director, >10% Owner
Bought$1244523
Sep 05, 2023
Donald Olds
Director
Bought$781

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
37,584,856Insider399.86%108,244,385
5,064,694Insider53.88%14,586,319
1,919,625Insider20.42%5,528,520
1,312,420Insider13.96%3,779,770
911,200Insider9.69%2,624,256
545,340Insider5.80%1,570,579
485,965Insider5.17%1,399,579
318,014Insider3.38%915,880
239,630Insider2.55%690,134
117,500Insider1.25%338,400

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
3,058Institution0.03%8,807

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
1,832Institution0.02%5,240

FAQ

Who Owns Acasti Pharma, Inc. (ACST)?
Currently, no data Available
What percentage of Acasti Pharma, Inc. (ACST) stock is held by institutional investors?
Currently, no data Available
What percentage of Acasti Pharma, Inc. (ACST) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of Acasti Pharma, Inc. (ACST)?
Neptune Tech. Et Bioress. Inc. owns the most shares of Acasti Pharma, Inc. (ACST).
    What is the significance of the ownership structure for a publicly traded company?
    The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
      What's Included in PREMIUM?
      Make informed decisions based on Top Analysts' activity
      Know what industry insiders are buying
      Get actionable alerts from top Wall Street Analysts
      Find out before anyone else which stock is going to shoot up
      Get powerful stock screeners & detailed portfolio analysis